Epigral Ltd. (EPIGRAL) - Net Assets

Latest as of September 2025: Rs21.01 Billion INR ≈ $227.23 Million USD

Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has net assets worth Rs21.01 Billion INR (≈ $227.23 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs32.36 Billion ≈ $350.01 Million USD) and total liabilities (Rs11.35 Billion ≈ $122.78 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Epigral Ltd. liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs21.01 Billion
% of Total Assets	64.92%
Annual Growth Rate	24.07%
5-Year Change	178.39%
10-Year Change	545.28%
Growth Volatility	17.41

Epigral Ltd. - Net Assets Trend (2015–2025)

This chart illustrates how Epigral Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore Epigral Ltd. total assets for the complete picture of this company's asset base.

Annual Net Assets for Epigral Ltd. (2015–2025)

The table below shows the annual net assets of Epigral Ltd. from 2015 to 2025. For live valuation and market cap data, see EPIGRAL company net worth.

Year	Net Assets	Change
2025-03-31	Rs19.05 Billion ≈ $205.97 Million	+51.86%
2024-03-31	Rs12.54 Billion ≈ $135.63 Million	+17.30%
2023-03-31	Rs10.69 Billion ≈ $115.62 Million	+47.27%
2022-03-31	Rs7.26 Billion ≈ $78.51 Million	+6.12%
2021-03-31	Rs6.84 Billion ≈ $73.99 Million	+17.25%
2020-03-31	Rs5.83 Billion ≈ $63.10 Million	+18.41%
2019-03-31	Rs4.93 Billion ≈ $53.29 Million	-4.75%
2018-03-31	Rs5.17 Billion ≈ $55.95 Million	+43.02%
2017-03-31	Rs3.62 Billion ≈ $39.12 Million	+22.56%
2016-03-31	Rs2.95 Billion ≈ $31.92 Million	+34.01%
2015-03-31	Rs2.20 Billion ≈ $23.82 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Epigral Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 22055.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs17.85 Billion	93.72%
Common Stock	Rs431.40 Million	2.27%
Other Comprehensive Income	Rs-2.47 Billion	-12.95%
Other Components	Rs3.23 Billion	16.97%
Total Equity	Rs19.05 Billion	100.00%

Epigral Ltd. Competitors by Market Cap

The table below lists competitors of Epigral Ltd. ranked by their market capitalization.

Company	Market Cap
Qinghai Huzhu Barley Wine Co Ltd SHE:002646	$567.18 Million
AMERISAFE Inc NASDAQ:AMSF	$567.23 Million
Qingdao Liqun Department Store Group Co Ltd SHG:601366	$567.38 Million
Ningbo MedicalSystem Biotechnology Co Ltd SHE:300439	$567.44 Million
Indointernet Tbk PT JK:EDGE	$567.03 Million
MERSEN UNSP.ADR 1/5 EO 2 F:CBE0	$566.93 Million
COGNYTE SOFTWARE LTD F:81M	$566.87 Million
Peoples Fin NASDAQ:PFIS	$566.79 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Epigral Ltd.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 12,541,007,000 to 19,045,300,000, a change of 6,504,293,000 (51.9%).
Net income of 3,576,900,000 contributed positively to equity growth.
Dividend payments of 418,600,000 reduced retained earnings.
Share repurchases of 950,000,000 reduced equity.
Other factors increased equity by 4,295,993,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs3.58 Billion	+18.78%
Dividends Paid	Rs418.60 Million	-2.2%
Share Repurchases	Rs950.00 Million	-4.99%
Other Changes	Rs4.30 Billion	+22.56%
Total Change	Rs-	51.86%

Book Value vs Market Value Analysis

This analysis compares Epigral Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.70x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 39.06x to 2.70x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2015-03-31	Rs31.12	Rs1215.65	x
2016-03-31	Rs41.71	Rs1215.65	x
2017-03-31	Rs51.12	Rs1215.65	x
2018-03-31	Rs124.51	Rs1215.65	x
2019-03-31	Rs118.60	Rs1215.65	x
2020-03-31	Rs100.48	Rs1215.65	x
2021-03-31	Rs117.09	Rs1215.65	x
2022-03-31	Rs174.72	Rs1215.65	x
2023-03-31	Rs257.30	Rs1215.65	x
2024-03-31	Rs301.83	Rs1215.65	x
2025-03-31	Rs450.88	Rs1215.65	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Epigral Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 18.78%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 14.03%
• Asset Turnover: 0.81x
• Equity Multiplier: 1.66x
Recent ROE (18.78%) is below the historical average (23.66%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2015	15.75%	9.86%	0.66x	2.43x	Rs126.61 Million
2016	22.76%	16.87%	0.74x	1.83x	Rs376.67 Million
2017	18.40%	16.97%	0.74x	1.46x	Rs303.68 Million
2018	30.05%	26.04%	0.89x	1.30x	Rs1.04 Billion
2019	37.10%	25.74%	0.68x	2.12x	Rs1.34 Billion
2020	19.20%	18.36%	0.48x	2.18x	Rs536.51 Million
2021	14.74%	12.21%	0.57x	2.12x	Rs324.26 Million
2022	34.82%	16.31%	0.73x	2.93x	Rs1.80 Billion
2023	33.05%	16.28%	0.89x	2.28x	Rs2.46 Billion
2024	15.62%	10.34%	0.68x	2.23x	Rs704.56 Million
2025	18.78%	14.03%	0.81x	1.66x	Rs1.67 Billion

Industry Comparison

This section compares Epigral Ltd.'s net assets metrics with peer companies in the Chemicals industry.

Industry Context

Industry: Chemicals
Average net assets among peers: $6,787,048,222
Average return on equity (ROE) among peers: 11.22%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Epigral Ltd. (EPIGRAL)	Rs21.01 Billion	15.75%	0.54x	$567.17 Million
Archean Chemical Industries Limited (ACI)	$18.64 Billion	8.70%	0.28x	$810.84 Million
The Andhra Sugars Limited (ANDHRSUGAR)	$7.01 Billion	11.93%	1.00x	$143.16 Million
Bhansali Engineering Polymers Limited (BEPL)	$1.27 Billion	12.79%	1.76x	$258.72 Million
Chemplast Sanmar Limited (CHEMPLASTS)	$2.59 Billion	4.61%	6.39x	$390.88 Million
DCW Limited (DCW)	$6.87 Billion	0.55%	1.73x	$177.75 Million
Deepak Fertilizers and Petrochemicals Corporation Limited (DEEPAKFERT)	$20.86 Billion	7.80%	2.35x	$1.73 Billion
DIAMINES AND CHEMICALS ORD (BSE) (DIAMINESQ)	$849.87 Million	24.70%	0.12x	$28.60 Million
DMCC SPECIALITY CHEMICALS LIMITED (DMCC)	$2.10 Billion	5.53%	0.80x	$74.72 Million
Foseco India Limited (FOSECOIND)	$894.93 Million	24.38%	0.57x	$325.93 Million

About Epigral Ltd.

NSE:EPIGRAL India Chemicals

Market Cap

$567.17 Million

Rs52.44 Billion INR

Market Cap Rank

#11886 Global

#559 in India

Share Price

Rs1215.65

Change (1 day)

+1.77%

52-Week Range

Rs810.45 - Rs2088.70

All Time High

Rs2344.35